Literature DB >> 9681954

Dissociation of apolipoprotein and apolipoprotein receptor response to lesion in the rat brain: an in situ hybridization study.

K J Page1, R D Hollister, B T Hyman.   

Abstract

The epsilon4 allele of apolipoprotein E is associated with increased risk for developing Alzheimer's disease. To further understand the anatomical distribution of apolipoprotein E and its native receptors in the brain, we studied their messenger RNA expression in the adult rat brain under normal conditions and in response to an excitotoxic lesion to the hippocampus. In situ hybridization using oligonucleotide probes for apolipoprotein E, apolipoprotein J, the low density lipoprotein receptor, very low density lipoprotein receptor, low density lipoprotein receptor related protein, 39,000 mol. wt receptor-associated protein and glycoprotein 330/Megalin messenger RNA were performed on adjacent sections throughout the rat forebrain. Apolipoprotein E messenger RNA was abundantly expressed in the rat brain in both white and gray matter localizing to astrocytes but not neurons. Low density lipoprotein receptor-related protein and receptor-associated protein messenger RNA had a similar regional distribution but low density lipoprotein receptor-related protein messenger RNA was expressed by both neurons and glia, while the expression of receptor-associated protein messenger RNA was more highly expressed in neurons. Apolipoprotein J messenger RNA was expressed by neurons, glia and choroid plexus. The low density lipoprotein receptor and very low density lipoprotein receptor messenger RNA were found in both neurons and glia. Glycoprotein 330/Megalin messenger RNA was not detectable in the adult rat brain. In response to hippocampal lesions, apolipoprotein E and apolipoprotein J messenger RNAs were significantly up-regulated seven and 11 days post-lesion but the expression of low density lipoprotein receptor, low density lipoprotein receptor-related protein, receptor-associated protein, glycoprotein 330/Megalin, and very low density lipoprotein receptor messenger RNAs were unchanged. The expression of apolipoprotein E messenger RNA increased gradually beginning at three days while the expression of apolipoprotein J messenger RNA began to increase at seven days post-lesion. These findings further implicate apolipoproteins in the response of the brain to injury in vivo and suggest that transcriptional up-regulation of the apolipoprotein receptors studied is not a prominent feature in the response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681954     DOI: 10.1016/s0306-4522(97)00661-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

Review 1.  Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease.

Authors:  W G Wood; F Schroeder; N A Avdulov; S V Chochina; U Igbavboa
Journal:  Lipids       Date:  1999-03       Impact factor: 1.880

2.  Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain.

Authors:  S Grehan; E Tse; J M Taylor
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

Review 3.  Intracellular cholesterol and phospholipid trafficking: comparable mechanisms in macrophages and neuronal cells.

Authors:  G Schmitz; E Orsó
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

4.  Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2).

Authors:  Yuka Atagi; Chia-Chen Liu; Meghan M Painter; Xiao-Fen Chen; Christophe Verbeeck; Honghua Zheng; Xia Li; Rosa Rademakers; Silvia S Kang; Huaxi Xu; Steven Younkin; Pritam Das; John D Fryer; Guojun Bu
Journal:  J Biol Chem       Date:  2015-09-15       Impact factor: 5.157

5.  Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain.

Authors:  Eloise Hudry; Jonathan Dashkoff; Alysson D Roe; Shuko Takeda; Robert M Koffie; Tadafumi Hashimoto; Maria Scheel; Tara Spires-Jones; Michal Arbel-Ornath; Rebecca Betensky; Beverly L Davidson; Bradley T Hyman
Journal:  Sci Transl Med       Date:  2013-11-20       Impact factor: 17.956

6.  Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease.

Authors:  Yue Yang; C Dirk Keene; Elaine R Peskind; Douglas R Galasko; Shu-Ching Hu; Eiron Cudaback; Angela M Wilson; Ge Li; Chang-En Yu; Kathleen S Montine; Jing Zhang; Geoffrey S Baird; Bradley T Hyman; Thomas J Montine
Journal:  J Neuropathol Exp Neurol       Date:  2015-07       Impact factor: 3.685

7.  Identification of a non-canonical E-box motif as a regulatory element in the proximal promoter region of the apolipoprotein E gene.

Authors:  Enrique Salero; Cecilio Giménez; Francisco Zafra
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 8.  Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis.

Authors:  G William Rebeck
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain.

Authors:  Casandra M Cartagena; Farid Ahmed; Mark P Burns; Ahdeah Pajoohesh-Ganji; Daniel T Pak; Alan I Faden; G William Rebeck
Journal:  J Neurotrauma       Date:  2008-09       Impact factor: 5.269

10.  Function and comorbidities of apolipoprotein e in Alzheimer's disease.

Authors:  Valérie Leduc; Dorothée Domenger; Louis De Beaumont; Daphnée Lalonde; Stéphanie Bélanger-Jasmin; Judes Poirier
Journal:  Int J Alzheimers Dis       Date:  2011-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.